Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates - Yahoo Finance
14 hours ago • Google News
Krystal Biotech Inc (KRYS)
US$ 165.69-2.47%
Price Chart
Key Statistics
Market Cap
$ 4.8B
P/E Ratio
55.20
Revenue (TTM)
$ 290.52M
Volume
253.27K
52W High
$ 219.34
52W Low
$ 141.72
Dividend Yield
0.00%
Beta
0.75
Technicals
50-Day MA
176.1255
200-Day MA
177.6916
52 Week High
219.34
52 Week Low
141.72
About KRYS
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United S.
Employees
275
Headquarters
Pittsburgh, PA
CEO
Mr. Krish S. Krishnan M.B.A., M.S.
Latest News
Krystal Biotech is Now Oversold (KRYS) - Nasdaq
11 hours ago • Google News
Krystal Biotech Q1 Earnings and Sales Miss Estimates, Stock Down - TradingView
9 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg